Glyoxylate Reductase and Primary Hyperoxaluria
Glyoxylate Reductase and Primary Hyperoxaluria
批准号:
7983893
负责人:
ROSS P HOLMES
金额:
$10.42万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-11-25 至 2010-10-31
关键词:
AnionsBiological AssayBloodCalcium OxalateCalculiCell LineCellsChromatographyCollagenCoupledCultured CellsDataDegradation PathwayDepositionDetectionDiseaseEnzymesErythrocytesExcretory functionFunctional disorderGenesGenomicsGlycolatesGlyoxylatesGoalsHereditary DiseaseHumanHydroxyprolineHydroxypyruvate reductaseIncubatedIndividualInheritedInvestigationIonsKidneyKidney CalculiKidney FailureKidney TransplantationKnock-outKnockout MiceKnowledgeLeadLeftLiquid substanceLiverMeasuresMedicalMetabolicMetabolismModelingMonitorMusMutationOxalatesPathway interactionsPharmaceutical PreparationsPhenotypePrevention therapyPrimary HyperoxaluriaProductionRNA InterferenceReportingResearch PersonnelRoleSourceStudy modelsTestingTherapeuticTissuesUrineWestern Blottingadvanced diseasedesignefficacy testingenzyme deficiencyglyoxylateglyoxylate reductasehydroxyproline oxidaseinsightliver transplantationnovelnovel strategiesnovel therapeuticsphosphoglycolateprogramsresearch studytoolurinary
中文摘要
描述(由申请人提供):原发性高草酸尿症是一种罕见的遗传性疾病,由过量的内源性草酸合成引起。Glyoxylate reductase (GR)是这一生物合成途径中的关键酶,它将草酸盐的主要前体Glyoxylate转化为草酸盐,从而限制其向草酸盐的转化。该项目的长期目标是深入了解与GR活性、乙醛酸盐和草酸盐合成相关的途径,确定GR活性缺失的代谢后果,并确定在GR活性缺失时限制草酸盐合成的治疗策略。为了帮助实现这些目标,我们开发了一种GR活性降低的细胞系,并获得了一种缺乏GR活性的敲除(KO)小鼠。这项建议有三个具体目标。第一个目的是确定KO小鼠的表型,使用离子色谱耦合质谱检测(IC/MS)测量血液、尿液和组织中的阴离子浓度。第二个目的是验证抑制羟脯氨酸氧化酶(HPOX)将是减少与GR缺乏相关的草酸盐合成增加的有效治疗策略的假设。为了建立原理证明,RNA干扰将用于抑制HPOX活性并减少草酸盐合成。KO小鼠将被用作这些研究的模型。在第三个具体目标中,将研究GR在红细胞中的功能作用。与其他细胞相比,这些细胞具有简化的代谢,初步数据表明这些细胞含有乙醇酸盐、乙醛酸盐和草酸盐,以及GR活性。据推测,GR的作用是限制草酸盐的产生和合成乙醇酸盐,乙醇酸盐是合成磷酸乙醇酸盐的潜在底物。这些假设将在用乙醇酸和乙醛酸盐培养的KO小鼠细胞和人类细胞中进行测试。这些研究将增加我们对草酸盐合成相关代谢的理解,并有可能确定新的治疗策略来减少原发性高草酸尿中草酸盐的合成。
英文摘要
DESCRIPTION (provided by applicant): Primary hyperoxaluria is a rare, genetic disorder that results from an excessive endogenous synthesis of oxalate. Glyoxylate reductase (GR) is a key enzyme in this biosynthetic pathway, converting glyoxylate, the main precursor of oxalate, to glycolate and thereby limiting its conversion to oxalate. The long term goals of this project are to develop an in depth understanding of the pathways associated with GR activity and glyoxylate and oxalate synthesis, to determine the metabolic consequences of an absence of GR activity, and to identify therapeutic strategies that limit oxalate synthesis when the activity is absent. To assist with these goals we have developed a cell line with reduced GR activity and have obtained a knockout (KO) species of mouse lacking GR activity. This proposal has three specific aims. The first aim is to determine the phenotype of the KO mouse, measuring anion concentrations in blood, urine and tissues using ion chromatography coupled to mass detection (IC/MS). The second aim is designed to test the hypothesis that inhibiting hydroxyproline oxidase (HPOX) will be an effective therapeutic strategy for decreasing the increased oxalate synthesis associated with GR deficiency. To establish proof of principle, RNA interference will be utilized to inhibit HPOX activity and decrease oxalate synthesis. The KO mouse will be used as a model for these studies. In the third specific aim, the functional role of GR in red blood cells will be examined. These cells have a simplified metabolism in comparison to other cells and preliminary data indicate that these cells contain glycolate, glyoxylate and oxalate, as well as GR activity. It is hypothesized that GR functions to limit oxalate production and to synthesize glycolate, a potential substrate for phosphoglycolate synthesis. These hypotheses will be tested in cells from KO mice and human cells incubated with glycolate and glyoxylate. These studies will increase our understanding of the metabolism associated with oxalate synthesis and will potentially identify novel therapeutic strategies to decrease oxalate synthesis in primary hyperoxaluria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Influence of Obesity on Endogenous Oxalate Synthesis
-
批准号:10167931
-
项目类别:
-
资助金额:$25.02万
-
财政年份:2018
-
负责人:ROSS P HOLMES
-
依托单位:
Influence of Obesity on Endogenous Oxalate Synthesis
-
批准号:10265575
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2018
-
负责人:ROSS P HOLMES
-
依托单位:
Mitochondrial Metabolism in Primary Hyperoxaluria
-
批准号:8926129
-
项目类别:
-
资助金额:$5.85万
-
财政年份:2014
-
负责人:ROSS P HOLMES
-
依托单位:
12th International Symposium on Urolithiasis
-
批准号:8319718
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2012
-
负责人:ROSS P HOLMES
-
依托单位:
DIETARY FRUCTOSE AND URINARY OXALATE EXCRETION
-
批准号:8167038
-
项目类别:
-
资助金额:$6.92万
-
财政年份:2010
-
负责人:ROSS P HOLMES
-
依托单位:
Hydroxproline Catabolism and Hyperoxaluria
-
批准号:8075595
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2010
-
负责人:ROSS P HOLMES
-
依托单位:
INFLUENCE OF GLYCINE BLOOD CONCENTRATION ON ITS METABOLISM TO OXALATE
-
批准号:8167055
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2010
-
负责人:ROSS P HOLMES
-
依托单位:
Ninth International Primary Hyperoxaluria Workshop
-
批准号:8007053
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2010
-
负责人:ROSS P HOLMES
-
依托单位:
Hydroxproline Catabolism and Hyperoxaluria
-
批准号:7783704
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2010
-
负责人:ROSS P HOLMES
-
依托单位:
Hydroxproline Catabolism and Hyperoxaluria
-
批准号:8299599
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2010
-
负责人:ROSS P HOLMES
-
依托单位:
OXIDATION OF PHENYLALANINE TO OXALATE
-
批准号:7951419
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2009
-
负责人:ROSS P HOLMES
-
依托单位:
DIETARY FRUCTOSE AND URINARY OXALATE EXCRETION
-
批准号:7951413
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2009
-
负责人:ROSS P HOLMES
-
依托单位:
OXIDATION OF GLYCINE TO OXALATE
-
批准号:7951402
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2009
-
负责人:ROSS P HOLMES
-
依托单位:
11th International Symposium on Urolithiasis
-
批准号:7541090
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2008
-
负责人:ROSS P HOLMES
-
依托单位:
DIETARY PROTEIN AND ENDOGENOUS OXALATE SYNTHESIS
-
批准号:7607704
-
项目类别:
-
资助金额:$6.89万
-
财政年份:2007
-
负责人:ROSS P HOLMES
-
依托单位:
Endogenous Oxalate Synthesis
-
批准号:8108712
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2006
-
负责人:ROSS P HOLMES
-
依托单位:
Endogenous Oxalate Synthesis
-
批准号:7173714
-
项目类别:
-
资助金额:$28.56万
-
财政年份:2006
-
负责人:ROSS P HOLMES
-
依托单位:
Endogenous Oxalate Synthesis
-
批准号:7574376
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2006
-
负责人:ROSS P HOLMES
-
依托单位:
HYDROXYPROLIINE AND URINARY OXALATE EXCRETION
-
批准号:7376677
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2006
-
负责人:ROSS P HOLMES
-
依托单位:
Endogenous Oxalate Synthesis
-
批准号:8303229
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2006
-
负责人:ROSS P HOLMES
-
依托单位:
海外基金